At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
LCD Solution with NB-UVB Phototherapy +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Clinical Evaluation of Safety & Efficacy of Adding an At-home Topical LCD Solution Regimen to Standard Narrowband UVB Phototherapy Administered 3 Times Weekly to Adults With Generalized Plaque Psoriasis.
In Brief
A clinical study evaluating LCD Solution with NB-UVB Phototherapy and NB-UVB Light Device (311-315 nm) for Plaque Psoriasis. Completed, enrolled 12 participants across 1 site.
Detailed Summary
The purpose of this study is to determine if combining a daily at-home regimen using an LCD Solution with a 3 times weekly outpatient narrowband UVB phototherapy regimen could be a safe, effective, rapid, and, convenient treatment for plaque psoriasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2007
Primary CompletionJan 2008
Study CompletionMar 2008
First PostedJul 2008
TodayJul 2026
First PostedJul 2, 2008
Enrollment StartApr 1, 2007
Primary CompletionJan 1, 2008
Study CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 18 years ago
Interventions
LCD Solution with NB-UVB Phototherapyother
LCD Solution: 2 applications / day NB-UVB Phototherapy: 3 light sessions / week
NB-UVB Light Device (311-315 nm)device
NB-UVB Phototherapy: 3 light exposures / week